Partnervest Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Partnervest Advisory Services's BMY Position: Q3 2020 in Review
Partnervest Advisory Services increased its Bristol-Myers Squibb (BMY) stake by 7.6% in Q3 2020, buying an estimated $18.1K and bringing the position to 4,257 shares worth $257K. The position accounts for 0.08% of the portfolio, ranked #192.
Partnervest Advisory Services first reported a position in BMY in Q2 2013 and has held it in 18 quarters since. The position peaked at $794K in Q3 2017. 2,214 funds tracked by Wall St. Rank hold BMY as of Q3 2020.
- Partnervest Advisory Services held 4,257 shares of Bristol-Myers Squibb worth $257K as of Q3 2020.
- Partnervest Advisory Services bought 301 Bristol-Myers Squibb shares in Q3 2020, an estimated $18.1K.
- Bristol-Myers Squibb made up 0.08% of Partnervest Advisory Services's portfolio in Q3 2020, its #192 holding.
- Partnervest Advisory Services first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 18 quarters since.
- Partnervest Advisory Services's Bristol-Myers Squibb position peaked at $794K in Q3 2017.
- 2,214 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.
Based on Partnervest Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.